← Open Payments lookup

RICHARD ULSTAD: Open Payments

NPI 1356304810 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$600 in 27 payments from 12 companies in 2025. Trend: 2023 $289 · 2024 $1,013 · 2025 $600

Food & beverage: $600
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.6$172
Boehringer Ingelheim Pharmaceuticals, Inc.4$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$72
AstraZeneca Pharmaceuticals LP3$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$47
Novo Nordisk Inc2$40
PFIZER INC.2$37
Takeda Pharmaceuticals U.S.A., Inc.1$27
Exact Sciences Corporation1$16
TOLMAR, INC.1$16

Products named: Kerendia, JARDIANCE, CAPLYTA, FARXIGA, XIFAXAN, TRINTELLIX, PAXLOVID, Wegovy.

Industry payments across NC — which companies pay providers there.